ANTIMANIA DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Antimania Drugs Market - Overview Global Antimania Drugs Market Drivers The global Antimania Drugs Market is expected to witness significant growth over the forecast period, owing to growing prevalence of bipolar disorder, globally. For instance, according to the World Health Organization (WHO) 2019 report, around 45 million people get affected by bipolar disorder globally.
Antimania drugs are used in the treatment of bipolar disorder, a type of mood disorder also called as manic depression or manic-depressive illness, where patient’s mood fluctuate from feeling depressed to feeling super charged or manic. The most widely used medication for the treatment of acute mania include lithium, valproate & carbamazepine (antipsychotics), ziprasidone, aripiprazole & clozapine (atypical antipsychotics), and lorazepam (benzodiazepine). Additionally, for the treatment of prophylaxis of bipolar mood disorder, lithium carbonate and lithium citrate are mostly used. Carbamazepine reduces transmission of the nerve impulse in the brain, which in turn reduces severity of manic episodes. Moreover, carbamazepine can be used as alternative to lithium salts, when patients fails to respond to lithium. Furthermore, sometimes carbamazepine are used with the combination of lithium, when there is need of rapid control of acute mania. Browse Research Reports: https://www.coherentmarketinsights.com/ongoinginsight/antimania-drugs-market-4143 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Moreover, cost effectiveness of drugs for the treatment of bipolar disorder is another factor that is expected to drive the global antimania drugs market growth over the forecast period. For instance, cost of olanzapine is US$ 153, while cost of lithium is US$ 16 per month. Furthermore, increasing number of clinical trials of drug for the treatment of bipolar depression, which is expected to propel the global antimania drugs market growth over the forecast period. For instance, in July 2018, Lumateperone received positive results from the Phase 3 clinical trial (Study 401 and Study 404) for the treatment of bipolar depression, announced by Intra-Cellular Therapies, Inc. In both the trials (Study 401 and Study 404), Lumateperone was found safer and tolerable by patients. Moreover, in October 2019, Psychiatry Consortium, which is a strategic collaboration of leading medical research charities and pharmaceutical companies to accelerate innovative drug discovery in psychiatric diseases, had announced to launch a novel drug project to address people with mental health conditions such as bipolar disorder, depression and other mental disorders. Psychiatry Consortium is a pioneering collaboration between the pharmaceutical companies, healthcare companies as well as leading medical charities. Therefore, increasing initiatives by companies to support the novel drug project, which in turn, is expected to increase the launch of new drugs for treatment of patients with mental health condition such as bipolar disorder and hence drives the global antimania drugs market growth. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4143 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Antimania Drugs Market Regional Analysis North America is expected to hold the highest market share in global antimania drugs market, owing to factors such as increasing technological advancements such as BiAffect app by University of Illinois, Chicago that helps to facilitate accurate detection of a patient’s mood and mental state. For instance, in 2018, the University of Illinois, Chicago (UIC) launched BiAffect app, which helps to track manic disorder and depressive mood in the patient with biopolar disorder. Moreover, BiAffect app predict mood episodes by analyzing the stroke dynamics such as error and typing speed of the patient. Therefore, launch of BiAffect app is expected to drive demand of antimania drugs for the treatment of bipolar disorder. Moreover, increasing approvals of drug such as Vraylar by U.S Food and Drug administration (FDA) for the treatment of bipolar disorder is another factor that is expected to boost global antimania drugs market growth. For instance, in May 2019, Allergan plc and Gedeon Richter Plc announced to receive the approval from the U.S Food Drug Administration for expanded use of Vraylar (cariprazine) in the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults. Among regions, Europe is expected to hold the second highest market share in global antimania drug market, owing to increasing launches of new drugs for the treatment of bipolar disorder in Europe. Additionally, the National Medical Products Administration (NMPA) has granted import drug license for LATUDA drug in China.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4143 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved